Patent

US Patent Office Chief Kathi Vidal to Depart, Returns to Private Sector Ahead of Presidential Transition

by

Washington, D.C. – Kathi Vidal, current head of the U.S. Patent and Trademark Office and a former intellectual property lawyer in Silicon Valley, is set to leave her federal position next month, transitioning back to the private sector. Vidal, appointed by President Joe Biden, has served as the undersecretary of commerce for intellectual property since her confirmation in 2022. Her departure coincides with the anticipated inauguration of President-elect Donald Trump on January 20, sparking interest about the timing and implications of her transition. Deputy Director Derrick Brent will step in as interim head following Vidal’s … Read more

Federal Judge Decides Against Dexcom in Patent Infringement Case Over Glucose Monitor Technology

by

Wilmington, Delaware — A recent legal decision has marked a significant development in the medical technology industry, as Dexcom Inc. has been found to have infringed on a glucose monitor patent held by an Abbott Laboratories unit. This ruling by a Delaware judge resolved a previously undecided matter left by a federal jury in March, which had been unable to reach a verdict on the case. The dispute centers on Dexcom’s use of specific patented technology crucial to glucose monitoring devices that play a vital role in diabetes management. These devices continually measure the glucose … Read more

Netflix Wins Patent Dispute, Overturns $2.5 Million Jury Verdict on Wireless Content Rendering Claims

by

Netflix Inc. recently achieved a significant victory in a legal battle over patent claims related to technology for streaming content on wireless devices. The streaming giant successfully persuaded an administrative tribunal to invalidate parts of two patents held by GoTV Streaming LLC. This followed a previous loss in court that resulted in a $2.5 million jury verdict against Netflix. The key patents in question, identified as U.S. Patent Nos. 8,989,715 and 8,478,245, include claims that the Patent Trial and Appeal Board deemed obvious based on prior inventions. This decision, issued on Tuesday, follows a contentious … Read more

Emboline Takes Legal Action Against AorticLab for Alleged Patent Violations on Stroke Prevention Device

by

Munich, Germany – In a significant move within the medical device industry, Emboline, a pioneering medical technology company, has initiated a patent infringement lawsuit against AorticLab based in Italy. This legal action, filed on October 28 at the Unified Patent Court’s local division in Munich, centers on claims that AorticLab has unlawfully utilized Emboline’s patented technology in their products. Emboline’s claims involve its specialized embolic protection device, specifically designed to safeguard against ischemic events such as strokes during transcatheter heart procedures. This cutting-edge device, known as the Emboliner Embolic Protection Catheter, is crucial in capturing … Read more